Potential COVID-19 Products: Choosing The Right Path With FDA

Information is being shared by FDA in an ongoing fashion as they manage the response to the current COVID-19 pandemic for ongoing and planned clinical research. If you are considering development of a product for treatment of COVID-19 or COVID-19-related indications, ensuring no time is wasted between idea and engaging FDA via the appropriate pathway with all the required information is essential.  In this webinar, we’ll review the pathways you might consider, based on the development phase and overall goals for your product, and discusses the information and data necessary to help FDA expeditiously review your proposal and move it forward.